EISAI INC. for EISAI INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Medicare & Medicaid policy & reimbursement for drugs Prescription drug safety legislation PDUFA reauthorization Follow-on biologies Alzheimer's disease legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FEENEY New | — |
| JENNIFER GRUBER New | — |
Medicare/Medicaid MMM
Medicare & Medicaid policy & reimbursement for drugs Prescription drug safety legislation PDUFA reauthorization Follow-on biologies Alzheimer's disease legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FEENEY New | — |
| JENNIFER GRUBER New | — |
Medical/Disease Research/Clinical Labs MED
Medicare & Medicaid policy & reimbursement for drugs Prescription drug safety legislation PDUFA reauthorization Follow-on biologies Alzheimer's disease legislation
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FEENEY New | — |
| JENNIFER GRUBER New | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| EISAI CO. LTD. | Japan | Japan | 100.0% | — |
Affiliated organisations
| Organisation | Location |
|---|---|
| EISAI CO. LTD. | Bunkyo-Ku, Tokyo, JP |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.